TipRanks

Garen Bohlin Insider Profile

4 Followers
Garen Bohlin, Director at Karyopharm Therapeutics, holds 18.52K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 0.00 shares in Tetraphase (Ticker: TTPH), holds 71.00K shares in Collegium Pharmaceutical (Ticker: COLL).
tipranks
Garen Bohlin

Garen Bohlin
Karyopharm Therapeutics (KPTI)
Director

Ranked #65,791 out of 109,030 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-6.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
87.16%
11.24%
1.60%
A breakdown of Garen Bohlin's holdings

Insider Roles

Collegium Pharmaceutical
(COLL)
Director
Protara Therapeutics
(TARA)
Director
Karyopharm Therapeutics
(KPTI)
Director
Roles that Garen Bohlin holds in companies

Most Profitable Insider Trade

Stock:
Collegium Pharmaceutical
(COLL)
Rating:Informative Sell
Date:May 13, 2026 - Today
Return:+34.70%
The most profitable trade made by Garen Bohlin

Garen Bohlin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Karyopharm Therapeutics
May 26, 2026
Director
Uninformative Buy
$28.52K
TTPH
Tetraphase
$0.00
Collegium Pharmaceutical
May 18, 2026
Director
Uninformative Buy
$1.55M
Protara Therapeutics
Nov 14, 2017
Director
Uninformative Buy
102.90K
$199.92K
List of latest transactions for each holding click on a transaction to see Garen Bohlin's performance on stock

Garen Bohlin insider profile FAQ

What is the percentage of profitable transactions made by Garen Bohlin?
The percentage of profitable transactions made by Garen Bohlin is 50%.
    What is the average return per transaction made by Garen Bohlin?
    The average return per transaction made by Garen Bohlin is -6.70%.
      What stocks does Garen Bohlin hold?
      Garen Bohlin holds: KPTI, TTPH, COLL, TARA stocks.
        What was Garen Bohlin’s latest transaction?
        Garen Bohlin latest transaction was an Uninformative Buy of ―.
          What was Garen Bohlin's most profitable transaction?
          Garen Bohlin’s most profitable transaction was an Informative Sell of COLL stock on May 13, 2026. The return on the trade was 34.70%.
            What is Garen Bohlin's role in Karyopharm Therapeutics?
            Garen Bohlin's role in Karyopharm Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.